Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
8 hedge funds and large institutions have $905K invested in Genetic Technologies Ltd. in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
7% more capital invested
Capital invested by funds: $845K → $905K (+$60K)
20% less funds holding
Funds holding: 10 → 8 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$205K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$23.5K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$1.98K |
| 4 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$829 |
| 5 |
Citigroup
New York
|
+$645 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20K |
| 3 |
Morgan Stanley
New York
|
-$12.6K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.99K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $843K | +$205K | +4,455 | +28% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $31K | +$1.98K | +43 | +6% |
|
|
3
UBS Group
Zurich,
Switzerland
| $21K | +$23.5K | +510 | New |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | – | – | – |
|
|
5
Morgan Stanley
New York
| $2K | -$12.6K | -274 | -85% |
|
|
6
Citigroup
New York
| $1K | +$645 | +14 | +1,400% |
|
|
FANJ
7
Financial Architects (New Jersey)
Marlton,
New Jersey
| $1K | +$829 | +18 | New |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$38K | -818 | Closed |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$20K | -425 | Closed |
|
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5.99K | -130 | -86% |
|
|
11
Creative Planning
Overland Park,
Kansas
| – | -$1K | -25 | Closed |
|
GENE Hedge Fund Activity: Q2 2016 in Review
8 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2016, worth a combined $905K — up 7.1% from $845K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GENE and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $205K. The largest seller was Citadel Advisors, exiting entirely with an estimated $38K sold.
- 8 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2016, down from 10 in Q1 2016.
- Funds reported $905K of Genetic Technologies Ltd. stock for Q2 2016, up 7.1% quarter-over-quarter.
- 2 funds opened new Genetic Technologies Ltd. positions in Q2 2016 and 4 closed out, a net change of -2 holders.
- The largest Genetic Technologies Ltd. buyer in Q2 2016 was Renaissance Technologies, an estimated $205K added.
- The largest Genetic Technologies Ltd. seller in Q2 2016 was Citadel Advisors, an estimated $38K sold.
Based on aggregated 13F filings for Q2 2016.